GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (OSTO:BICO) » Definitions » ROE % Adjusted to Book Value

BICO Group AB (OSTO:BICO) ROE % Adjusted to Book Value : 63.66% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BICO Group AB ROE % Adjusted to Book Value?

BICO Group AB's ROE % for the quarter that ended in Dec. 2024 was 48.38%. BICO Group AB's PB Ratio for the quarter that ended in Dec. 2024 was 0.76. BICO Group AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 63.66%.


BICO Group AB ROE % Adjusted to Book Value Historical Data

The historical data trend for BICO Group AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB ROE % Adjusted to Book Value Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only -1.17 -2.15 -11.28 -17.94 -0.24

BICO Group AB Quarterly Data
Nov19 Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.21 -3.35 -9.83 -30.32 63.66

Competitive Comparison of BICO Group AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, BICO Group AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BICO Group AB's ROE % Adjusted to Book Value falls into.



BICO Group AB ROE % Adjusted to Book Value Calculation

BICO Group AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-0.18% / 0.76
=-0.24%

BICO Group AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=48.38% / 0.76
=63.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BICO Group AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of BICO Group AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BICO Group AB Business Description

Traded in Other Exchanges
Address
Langfilsgatan 9, Gothenburg, SWE, 41277
BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).

BICO Group AB Headlines

No Headlines